| CAS NO: | 1173147-93-7 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| Cas No. | 1173147-93-7 |
| 别名 | 二氟沙星-D3 |
| Canonical SMILES | OC(C1=CN(C2=CC=C(F)C=C2)C3=CC(N4CCN(C([2H])([2H])[2H])CC4)=C(F)C=C3C1=O)=O |
| 分子式 | C21H16D3F2N3O3 |
| 分子量 | 402.4 |
| 溶解度 | Chloroform: soluble,Ethanol: soluble |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Difloxacin-d3is intended for use as an internal standard for the quantification of difloxacin by GC- or LC-MS. Difloxacin is a fluoroquinolone antibiotic.1It is active against isolates of anaerobic bacteria, includingB. fragilis, as well asFusobacteriumandActinomycesspecies with MIC values ranging from ≤0.125 to 8 µg/ml. It eliminatesE. coliandB. fragilisinfection in a rat intra-abdominal abscess model when administered at a dose of 40 mg/kg three times per day.2 1.Bansal, M.B., and Thadepalli, H.Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitroAntimicrob. Agents Chemother.31(4)619-621(1987) 2.Thadepalli, H., Gollapudi, S.V., and Chuah, S.K.Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscessAntimicrob. Agents Chemother.30(4)574-576(1986) |
m.cnreagent.com